Companies/US/FDMT

4D MOLECULAR THERAPEUTICS, INC.

Income flow

Annual
FDMT 10-K Income StatementPeriod 2025-12-31Source 10-K
Collaboration And License Revenue$85MRevenue$85M+230195% Y/Y

As-filed revenue segments and annual P&L (gross, opex, tax, net). Layout inspired by SankeyArt finance diagrams.

Revenue mix

2025-12-31 · 10-K · USD
By activity
By activity$85M
  • Collaboration And License Revenue$85M100.0%
By geography
By geography$85M
  • JP$85M99.8%
  • United States$209,0000.3%

Capital & dividends

YieldTrailing twelve-month dividends as a percent of the current share price (income yield).0.00%Trailing DPSCash dividends paid per share over the last twelve months (dividend per share, trailing).0Shares outTotal shares currently outstanding (issued and not retired).55.2MFloatShares available to trade — outstanding minus closely held (insiders, strategic holders).42.6M